BioCentury
ARTICLE | Company News

Oncomatrix sales and marketing update

March 11, 2013 7:00 AM UTC

Oncomatrix launched DMTXinvaScan immunohistochemistry kit worldwide to diagnose and prognose the invasiveness of tumors. The DMTXinvaScan uses a mAb developed by Oncomatrix to detect collagen type X...